News

Filter by Category

All Annual Meetings Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Date

August 10, 2018

CPAD Has Two Posters Accepted to Alzheimer’s Association International Conference

The Alzheimer’s Association International Conference (AAIC) is the largest annual scientific meeting with focus on Alzheimer dis

August 10, 2018

Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment

The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public worksho

July 26, 2018

First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials

FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com Tucson, AZ — July 26, 2018 – The Criti

May 18, 2018

“Improving Clinical Trials to Deliver Better Treatments,” as featured in the Spring 2018 edition of “Progress, the research magazine of Parkinson’s UK”

May 7, 2018

C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)

TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

April 26, 2018

CPTR Newsletter – April 2018

CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collabora

April 16, 2018

Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease Biomarkers

Tucson, AZ, and New York, NY – April 16, 2018 — The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path

February 12, 2018

Tucson-based Critical Path Institute emerging as top drug-research organization

President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published Februa

February 5, 2018

Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed

Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Wor

October 24, 2017

US FDA Awards I-ACT for Children a Grant for Pediatric Medicines and Devices Network

Previous2223 24...35 Next